Julie McHugh

Julie McHugh

Fortune : 4 M $ au 31/07/2026

61 ans
Health Technology
Commercial Services
Consumer Services

Profil

Julie Harris McHugh is currently Chairman at Ironwood Pharmaceuticals, Inc. since 2019.
Director at Lantheus Medical Imaging, Inc. since 2017.
Director at Xellia Pharmaceuticals ApS since 2013.
Director at The Nathaniel Adamczyk Foundation.
Lead Independent Director at Lantheus Holdings, Inc. since 2024.
Director at New Xellia Group A since 2013.
Advisor at Healthcare Royalty Management LLC since 2016.
Former Chief Executive Officer at Nora Therapeutics, Inc. in 2009.
Group Chairman-Worldwide Virology Business Unit at Johnson & Johnson from 2006 to 2008.
Chairman at Life Sciences Pennsylvania.
Director at Shire ViroPharma, Inc. from 2012 to 2014.
Director at Penwest Pharmaceuticals Co. Independent Director at Aerie Pharmaceuticals, Inc. from 2015 to 2022.
Director at Biotechnology Innovation Organization.
Director at New England Healthcare Institute.
Director at Xellia Pharmaceuticals AS.
Independent Director at Trevena, Inc. from 2014 to 2021.
Director at Zalicus, Inc. Director at Bucks County Biotechnology Center, Inc. Independent Director at EPIRUS Biopharmaceuticals, Inc. from 2014 to 2016.
Director at Evelo Biosciences, Inc. from 2021 to 2023.
Director at Viropharma, Inc. from 2012 to 2014.
President at Centocor, Inc. from 2004 to 2006.
Chief Operating Officer at Endo Health Solutions, Inc. from 2010 to 2013.
Education includes undergraduate degree from The Pennsylvania State University and MBA from St. Joseph's University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
14/05/2026 30 099 ( 0,05 % ) 3 M $ 31/07/2026
16/06/2026 250 749 ( 0,15 % ) 1 M $ 31/07/2026

Postes actifs de Julie McHugh

SociétésPosteDébut
IRONWOOD PHARMACEUTICALS, INC. Président 01/04/2019
LANTHEUS HOLDINGS, INC. Directeur/Membre du Conseil 01/01/2017
Directeur/Membre du Conseil 01/09/2013
Consultant / Advisor 01/01/2016
Directeur/Membre du Conseil 01/02/2017
Directeur/Membre du Conseil 01/09/2013
The Nathaniel Adamczyk Foundation
Directeur/Membre du Conseil 07/10/2010

Anciens postes connus de Julie McHugh

SociétésPosteFin
EVELO BIOSCIENCES, INC. Directeur/Membre du Conseil 11/07/2023
AERIE PHARMACEUTICALS, INC. Directeur/Membre du Conseil 21/11/2022
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Julie McHugh

Formation de Julie McHugh

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

77

Relations au 1er degré

26

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées26

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Finance

Commercial Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

The Nathaniel Adamczyk Foundation

Health Technology

Commercial Services

Health Technology

Finance

Health Technology

Viropharma, Inc.

  1. Bourse
  2. Insiders
  3. Julie McHugh
🔇